Opinions
The Panic-Proof Portfolio (Stockchase Research)
CorMedix Inc.
CRMD-Q
TOP PICK
Sep 04, 2025
N/A
Stock price when the opinion was issued
Healthcare
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
CRMD is beginning to see fruit of its antimicrobial catheter lock -- the first and only in the heath space introduced in last year -- that has been clinically proven to reduce infection by over 70% (a BIG cost saver to health plans). It trades at 17x earnings, 4x book and supports a robust 38% ROE. We recommend setting a stop-loss at $9.50, looking to achieve $17.00 -- upside potential of 28%. Yield 0%
(Analysts’ price target is $19.50)